Completion of Placing

This declaration must not be sent or transmitted, straightforwardly or in a roundabout way, into the United States, Australia, Canada or Japan and is not for conveyance, specifically or in a roundabout way in the United States, Australia, Canada or Japan or whatever other ward where the augmentation or accessibility of the raising support (and some other exchange considered along these lines) would (i) result in a prerequisite to follow any legislative or other assent or any enrollment documenting or other custom which InnovaDerma views as unduly burdensome, or (ii) generally rupture any relevant law or direction.

�

InnovaDerma PLC

("InnovaDerma" or the "Organization")

Consummation of Placing

InnovaDerma (LON: IDP), a UK engineer of 'at-home' and clinically demonstrated medications for male pattern baldness, hair mind, self-tanning and skin restoration, reported on 25 November 2016 that it had raised �539,999.60 preceding costs, through the setting by Hybridan LLP of 771,428 new normal shares of �0.10 each in the capital of the Company (the "Putting Shares") at a putting cost of 70 pence per impart to new institutional shareholders.

Application has been made for the Placing Shares to be admitted to the Official List and to exchanging on the London Stock Exchange's primary market for recorded securities. It is normal Admission will get to be distinctly compelling and that unqualified dealings will initiate on the London Stock Exchange at 8.00 a.m. on 9 December 2016. The Placing Shares will rank�pari passu�with the current common shares of the Company. Taking after Admission, the Company will have 11,116,963 standard partakes in issue. This figure (11,116,693), is the number which might be utilized by shareholders as the denominator for the computations by which they will figure out whether they are required to inform their enthusiasm for, or a change to their interests in, the Company under the FCA's Disclosure and Transparency Rules.

�

Utilization of Proceeds

�

The net continues of the gathering pledges will furnish the Company with working cash-flow to reserve development into European and US advertises and enhance production network administration to take care of developing demand for Skinny Tan, a top notch self-leather expert brand that contains a characteristic tanning dynamic, to tan and diminish the noticeable appearance of cellulite.*

�

*Based on Skinny Tan Consumer inquire about trial comes about.

�

Agent Warrants

�

Regarding the Placing, the Company has consented to issue warrants to Hybridan LLP to subscribe for up to 42,429 conventional partakes in the capital of the Company ("Broker Warrants").

The Broker Warrants are exercisable in the period from (however barring) 29 July 2016 to (and including) 29 July 2019, at a practice cost of �0.84 for every share.

�

Assist enquiries:

InnovaDerma

Haris Chaudhry/Joe Bayer

�

+61 (0)3 9111 0071

Sole intermediary

Hybridan LLP

Claire Noyce

�

+44 (0)203 764 2341

Cardew Group

Shan Willenbrock

David Roach

Emma Ruttle

�

+ 44 (0)20 7930 0777

�

�

About InnovaDerma:

InnovaDerma PLC�(LSE: IDP) represents considerable authority in the examination, make and showcasing of clinically demonstrated items in male pattern baldness, hostile to maturing and magnificence areas. InnovaDerma has nearness in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

�